Although overexpression of CD44 was indicated as an important prognostic parameter in 39 patients with osteosarcoma in a previous study, another group showed that CD44 immunoexpression could not predict the prognosis for 34 osteosarcoma patients17, 29. This evidence concerns the gene CD44 and osteosarcoma.